Back

Impact of sacubitril-valsartan compared to angiotensin inhibition on ventricular tachycardia burden in heart failure patients with reduced ejection fraction and implantable defibrillator

25 May 2019 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Treatment Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Konstantinos Polymeropoulos

General Hospital G. Papanikolaou, Thessaloniki (Greece)

60 More presentations in this session

Presentation thumbnail
Doctor A. Gkouziouta (Athens, GR)
Abstract
Presentation thumbnail
Doctor A. Gkouziouta (Athens, GR)
Abstract
Presentation thumbnail
Doctor L. Nelson (Copenhagen, DK)
Abstract
Presentation thumbnail
Doctor R. Chand (Los Angeles, US)
Abstract Slides
Presentation thumbnail
Doctor L. Vojtickova (Prague, CZ)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2019

25 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The effect of sacubitril/valsartan on device detected arrhythmias and electrical parameters among cardiac resynchronization therapy implanted patients with moderately reduced ejection fraction
29 June 2021
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Session
Evolution in pacing and risk management strategies in sudden cardiac death
31 March 2025
thumbnail
ESC Journals
Right ventricular strain as prognostic marker in patients with heart failure receiving sacubitril/valsartan: a sub-analysis of DISCOVER-ARNI, a multicenter Italian study
29 January 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources